Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations.

Despite a challenging macroeconomic environment, Pacific Biosciences of California Inc (PACB) reports strategic growth and ...

CEO Christian Henry highlighted Q4 2024 revenue of $39.2 million, driven by the shipment of 23 Revio systems and the early shipment of seven Vega benchtop platforms, which exceeded schedule. Full-year ...

While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key ...

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Institutional investors advised by J.P. Morgan Asset Management in partnership with the principals of Georgia Capital, an Atlanta-based residential investment and development firm, and its affiliated ...

Hugh O'Neill conducts plant cell wall research as part of the DOE Solvent Disruption of Biomass and Biomembranes Science ...

Dr. Hester Petty said three memorable experiences in her life involving discrimination always kept her motivated to fight for ...

A new BD will have four new operating segments: medical essentials, connected care, BioPharma systems and interventional.

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery ...

SEC Commissioner Hester Peirce has said that it’s been “extremely frustrating” watching what’s been happening within crypto when people want to try new things.